vTv Therapeutics Inc.
VTVT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641489
No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +11 vs. previous quarter
- 45
- 13F valueReported value at the end of Q2 2026
- $60.5M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding VTVT, Q2 2026
No superinvestor reported holding VTVT at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by vTv Therapeutics Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 (view filing) | Nov 15-18 | 4 days | Sekhri Paul JPres, CEO and Exec Chairperson | PPurchaseClass A Common Stock | +5.00K | $16.76 | +$83.8K | New position5.00K after | 3 lots10b5-1 |
| Nov 30, 2022 (view filing) | Nov 28-29 | 2 days | Fry John ADirector | PPurchaseClass A common stock | +61.0K | $0.83 | +$50.6K | New position61.0K after | 2 lots |
| Dec 21, 2021 (view filing) | Dec 20 | 1 day | Perelman Ronald O10% Owner | SSaleClass A Common Stock | −87.0K | $1.15 | −$100.0K | −0.2%36.5M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in vTv Therapeutics Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 298,496 | $11.2M | 0.92% | 00.0% | Unchanged |
| Millennium Management LLC | 269,874 | $10.2M | 0.01% | +63,586+30.8% | Added |
| FMR LLC | 260,391 | $9.80M | 0.00% | 00.0% | Unchanged |
| Siren, L.L.C. | 163,000 | $6.14M | 0.12% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 148,314 | $5.58M | 0.03% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 94,463 | $3.56M | 0.00% | −14,459−13.3% | Reduced |
| Trails Edge Capital Partners, LP | 85,192 | $3.21M | 0.51% | −54,386−39.0% | Reduced |
| Aisling Capital Management LP | 50,000 | $1.88M | 0.40% | +50,000 | New |
| Marshall Wace, LLP | 39,560 | $1.49M | 0.00% | +26,171+195.5% | Added |
| Geode Capital Management, LLC | 32,470 | $1.22M | 0.00% | −416−1.3% | Reduced |